Delivra Health Brands Inc V.DHB

Alternate Symbol(s): DHBUF

Healthcare Cannabis Psychedelics

Delivra Health Brands Inc. is a Canada-based consumer packaged goods company. The Company provides products that help with pain, sleep, anxiety, and performance through its acquired brands LivRelief and Dream Water. It operates a portfolio of brands under its Consumer Division consisting of Dream Products Inc. and its associated subsidiaries, and Delivra Corp. and its associated subsidiaries. Dream Water produces convenient, travel-friendly, single-serving 2.5oz liquid sleep shots, sleep powder packets that consumers can take with or without water and gummies. Its LivRelief brand offers relief for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and sports performance. It has also added three new products to its portfolio of licensed infused products: Transdermal 1:1 Cream- 250mg CBD:250mg THC; Transdermal CBD Cream with Cooling - 500mg CBD, and Extra Strength Transdermal CBD Cream: 1200mg CBD.

TSXV:DHB - Post by User

Delivra Health Brands Inc

Bullboard Posts

Post by Toptenconceptson Nov 11, 2017 7:08am

148 Views

Post# 26944506

how mmj new deal will help hvst

Date:: 11/11/17
Time:: 21:42:48
Post #:: 28706422

smk762 said: ↑

Mmj deal in oz with ese will help because

1. MMJ/HVST will potentially get direct access to supply for oils and vapes
2. MMJ/HVST will be an obvious fit for a strain developer to have a primary producer that can produce on demand and to their quality requirements.
3. oils, vapes & creams could potentially upgrade the value of the product from $10/g to $50/g
4. creams and topicals provide another avenue for product development that most other producers won't have access to and with the terpine development could improve efficacies far above any competitors.
5. Esense Lab are already producing products for market so it is a bonus that the R&D actually aligns and hopefully with cross-distributor rights that may come in the future could see additional avenues for revenues (based on HVST/MMJ import/export permits for European countries/Australia/Canada).
Just a few of my thoughts - I hope that I'm not reading too much into this but hopefully come Tuesday AG put's out a cracking release (probably best to let Esense handle the PR - IMO) and the market sees the potential.

Hvst capacity expansion my be expedited to push supply side